ArticleThe Journal of clinical investigation2008

Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity.

Rodger E Tiedemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.